{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:26:41Z","timestamp":1785364001548,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017676","name":"Chunhui Project Foundation of the Education Department of China","doi-asserted-by":"publisher","award":["HZKY20220587"],"award-info":[{"award-number":["HZKY20220587"]}],"id":[{"id":"10.13039\/501100017676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019063","name":"Tianjin Municipal Enterprise Technology Commissioner Project","doi-asserted-by":"publisher","award":["TJWJ2022MS014"],"award-info":[{"award-number":["TJWJ2022MS014"]}],"id":[{"id":"10.13039\/501100019063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Municipal Education Commission Scientific Research Program","award":["2022ZDGX20"],"award-info":[{"award-number":["2022ZDGX20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08210-w","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:02:29Z","timestamp":1722358949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The efficacy and safety of combination therapy of repeated low-level red light and defocus-incorporated multiple segments spectacle lenses for myopia control in children: the study protocol for a 12-month, randomized, parallel-controlled, and single-center clinical trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-506X","authenticated-orcid":false,"given":"Hongmei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"8210_CR1","doi-asserted-by":"publisher","first-page":"Mi","DOI":"10.1167\/iovs.18-25983","volume":"60","author":"S Resnikoff","year":"2019","unstructured":"Resnikoff S, Jonas JB, Friedman D, He M, Jong M, Nichols JJ, et al. Myopia - a 21st century public health issue. Invest Ophthalmol Vis Sci. 2019;60:Mi\u2013Mii.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"8210_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2471\/BLT.19.240903","volume":"98","author":"C Jan","year":"2020","unstructured":"Jan C, Li L, Keay L, Stafford RS, Congdon N, Morgan I. Prevention of myopia, China. Bull World Health Organ. 2020;98:435\u20137.","journal-title":"Bull World Health Organ"},{"key":"8210_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342.","journal-title":"Ophthalmology"},{"key":"8210_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.5.2","volume":"62","author":"P Sankaridurg","year":"2021","unstructured":"Sankaridurg P, Tahhan N, Kandel H, Naduvilath T, Zou H, Frick KD, et al. IMI impact of myopia. Invest Ophthalmol Vis Sci. 2021;62:2.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8210_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140:472\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"8210_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","volume":"129","author":"A Ha","year":"2022","unstructured":"Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis. Ophthalmology. 2022;129:322\u201333.","journal-title":"Ophthalmology"},{"key":"8210_CR7","first-page":"CD014758","volume":"2","author":"JG Lawrenson","year":"2023","unstructured":"Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;2:CD014758.","journal-title":"Cochrane Database Syst Rev."},{"key":"8210_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/cxo.12839","volume":"102","author":"P Cho","year":"2019","unstructured":"Cho P, Tan Q. Myopia and orthokeratology for myopia control. Clin Exp Optom. 2019;102:364\u201377.","journal-title":"Clin Exp Optom"},{"key":"8210_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1001\/jamaophthalmol.2017.1091","volume":"135","author":"Q Gong","year":"2017","unstructured":"Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, et al. Efficacy and adverse effects of atropine in childhood myopia: a meta-analysis. JAMA Ophthalmol. 2017;135:624\u201330.","journal-title":"JAMA Ophthalmol"},{"key":"8210_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1186\/s13063-021-05825-1","volume":"22","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Zhu C, Liu M, Zhou Y, Yang X, Zheng B, et al. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial. Trials. 2021;22:863.","journal-title":"Trials."},{"key":"8210_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1159\/000510779","volume":"64","author":"S Wang","year":"2021","unstructured":"Wang S, Wang J, Wang N. Combined orthokeratology with atropine for children with myopia: a meta-analysis. Ophthalmic Res. 2021;64:723\u201331.","journal-title":"Ophthalmic Res"},{"key":"8210_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1471-2415-14-141","volume":"14","author":"M-J Zhu","year":"2014","unstructured":"Zhu M-J, Feng H-Y, He X-G, Zou H-D, Zhu J-F. The control effect of orthokeratology on axial length elongation in Chinese children with myopia. BMC Ophthalmol. 2014;14:141.","journal-title":"BMC Ophthalmol"},{"key":"8210_CR13","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1038\/s41598-020-69710-8","volume":"10","author":"N Kinoshita","year":"2020","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kaburaki T, et al. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep. 2020;10:12750.","journal-title":"Sci Rep."},{"key":"8210_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, et al. Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129:509\u201319.","journal-title":"Ophthalmology"},{"key":"8210_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/tvst.11.10.33","volume":"11","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xiong R, Chen X, Zhang J, Bulloch G, Lin X, et al. Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: a randomized controlled trial. Transl Vis Sci Technol. 2022;11:33.","journal-title":"Transl Vis Sci Technol"},{"key":"8210_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ajo.2023.03.036","volume":"252","author":"J Tang","year":"2023","unstructured":"Tang J, Liao Y, Yan N, Dereje SB, Wang J, Luo Y, et al. Efficacy of repeated low-level red-light therapy for slowing the progression of childhood myopia: a systematic review and meta-analysis. Am J Ophthalmol. 2023;252:153\u201363.","journal-title":"Am J Ophthalmol"},{"key":"8210_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong J, Zhu Z, Xu H, He M. Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind, controlled clinical trial. Ophthalmology. 2023;130:198\u2013204.","journal-title":"Ophthalmology"},{"key":"8210_CR18","first-page":"1110","volume":"106","author":"CS Lam","year":"2022","unstructured":"Lam CS, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022;106:1110\u20134.","journal-title":"Br J Ophthalmol"},{"key":"8210_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY-Y, Lee RPK, Chun RKM, Hasegawa K, et al. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104:363\u20138.","journal-title":"Br J Ophthalmol."},{"key":"8210_CR20","doi-asserted-by":"publisher","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","volume":"115","author":"H Wu","year":"2018","unstructured":"Wu H, Chen W, Zhao F, Zhou Q, Reinach PS, Deng L, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci U S A. 2018;115:E7091\u2013100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8210_CR21","doi-asserted-by":"publisher","first-page":"102878","DOI":"10.1016\/j.ebiom.2020.102878","volume":"57","author":"F Zhao","year":"2020","unstructured":"Zhao F, Zhang D, Zhou Q, Zhao F, He M, Yang Z, et al. Scleral HIF-1\u03b1 is a prominent regulatory candidate for genetic and environmental interactions in human myopia pathogenesis. EBioMedicine. 2020;57:102878.","journal-title":"EBioMedicine"},{"key":"8210_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.62.15.30","volume":"62","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zhang S, Yang F, Yang Y, Huang Q, Huang C, et al. Decreased choroidal blood perfusion induces myopia in guinea pigs. Invest Ophthalmol Vis Sci. 2021;62:30.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8210_CR23","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1093\/gerona\/glaa155","volume":"75","author":"H Shinhmar","year":"2020","unstructured":"Shinhmar H, Grewal M, Sivaprasad S, Hogg C, Chong V, Neveu M, et al. Optically improved mitochondrial function redeems aged human visual decline. J Gerontol A Biol Sci Med Sci. 2020;75:e49-52.","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08210-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08210-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08210-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:05:03Z","timestamp":1722359103000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08210-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8210"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08210-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"18 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before the trial was initiated, this trial received ethical approval from the Institutional Review Board of Tianjin Medical University Eye Hospital (approval number: 2023KY-32).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"514"}}